Iva Igracki

Company: Glenmark Pharmaceuticals

Job title: Director, Medical Affairs Europe, Global Medical Lead, Innovative Dermatology Portfolio

Seminars:

Panel Discussion: Can Topical and Systemic Therapies Each Find Their Place in the Future of Dermatology Drug Development? 3:30 pm

How should we balance the clinical and commercial drivers behind topical and systemic innovation, especially as realworld prescribing habits continue to favor topicals? How are these approaches viewed from the patient, regulator and investor perspective? Which factors, including disease severity, body surface area, and treatment setting, best guide whether a topical, systemic, or combination approach…Read more

day: Day One PM

Workshop D: Closing the Gap from Approval to Implementation: Reviewing Market Access, Drug Pricing, Reimbursement 1:00 pm

With only 20% of patients being treated by approved therapies there are a huge portion of dermatology patients not receiving treatment they could benefit from. How can we best understand, break down and close this gap to ensure eligible patients can access treatment? Key Objectives Learn from Case-Based Presentations: Exploring successes and learnings in implementation…Read more

day: PRE-CONFERENCE WORKSHOP DAY Track B P2